| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
71,328 |
66,107 |
$5.63M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
57,924 |
53,797 |
$4.48M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
31,695 |
29,465 |
$2.58M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
16,662 |
15,854 |
$1.44M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
19,263 |
16,034 |
$99K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
380 |
340 |
$24K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
356 |
317 |
$23K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,063 |
2,480 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,607 |
8,670 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,892 |
5,962 |
$9K |
| 81003 |
|
10,291 |
8,919 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,737 |
1,550 |
$2K |
| 81025 |
|
2,112 |
1,803 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
324 |
297 |
$865.28 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
664 |
628 |
$78.62 |
| 83986 |
|
85 |
73 |
$43.67 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
14 |
$10.93 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
55 |
37 |
$1.29 |
| 99215 |
Prolong outpt/office vis |
43 |
35 |
$0.00 |